The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Potapova A.A.

Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii

Naumenko V.A.

Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii

Age-specific changes of serum alpha-fetoprotein levels in the subjects with inconclusive results of the detection of antibodies against hepatitis C virus

Authors:

Potekaev N.N., Potapova A.A., Naumenko V.A.

More about the authors

Read: 1520 times


To cite this article:

Potekaev NN, Potapova AA, Naumenko VA. Age-specific changes of serum alpha-fetoprotein levels in the subjects with inconclusive results of the detection of antibodies against hepatitis C virus. Russian Journal of Clinical Dermatology and Venereology. 2011;9(6):10‑13. (In Russ.)

References:

  1. Hajiani E., Masjedizadeh R., Hashemi J. et al. Hepatitis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol 2006; 12: 43: 7025-7028.
  2. Ward H., Day S., Weber J. Risk business: health and safety in the sex industry over a 9 year period. Sex Trans Infect 1999; 75: 5: 340-343.
  3. Bogush P.G., Redchenko E.B., Potapova A.A. i dr. Rasprostranenie antitel k virusu gepatita S sredi razlichnykh grupp riska v Moskve. Klin dermatol i venerol 2004; 1: 19-21.
  4. Gunn R.A., Murray P.J., Brennan C.H. et al. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project. Sex Transm Dis 2003; 30: 4: 340-344.
  5. Tedder R.S., Gilson R.J., Briggs M. et al. Hepatitis C virus: evidence for sexual transmission. Br Med J 1991; 302: 6788: 1299-1302.
  6. Kanestri V.G. Kombinirovannaya protivovirusnaya terapiya khronicheskogo gepatita S u bol'nykh VICh-infektsiei: Avtoref. dis. … kand. med. nauk. M 2001.
  7. Alter M.J., Kuhnert W.L., Finelli L. Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 2003; 52: RR-3: 1-13.
  8. Lobzin Yu.V., Zhdanov K.V., Gusev D.A. i dr. Klinicheskoe znachenie onkologicheskikh markerov pri khronicheskom gepatite S. Med akad zhurn 2005; 1: 67-73.
  9. et al. O primenenii v praktike zdravookhraneniya immunofermentnykh test-sistem dlya vyyavleniya poverkhnostnogo antigena virusa gepatita V (HBsAg) i antitel k virusu gepatita S (anti-VGS) v syvorotke krovi cheloveka. Prikaz MZ RF № 322 ot 21.10.02.
  10. Potapova A.A., Redchenko E.B., Naumenko V.A. Algoritm issledovaniya "problemnykh" obraztsov pri massovom skrininge syvorotki krovi na antitela k virusu gepatita S. Mir virusnykh gepatitov 2008; 4: 8-12.
  11. Glants S. Mediko-biologicheskaya statistika. M 1999.
  12. Piro L., Solinas S., Luciani M. et al. Prospective study of meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donors. Blood Transfus. 2008; 6: 2: 107-111.
  13. Rios M., Diago M., Rivera P. et al. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus. J Viral Hepat 2006; 13: 3: 177-181.
  14. D'yakova I.P. Osobennosti klinicheskoi kartiny i lecheniya HCV-infektsii u pozhilykh: Avtoref. dis. … kand. med. nauk. M 2005.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.